Home › Funds › Michelson Medical Research Foundation, Inc. › CNNE

Michelson Medical Research Foundation, Inc. position in CNNE

CANNAE HLDGS INC · Consumer Discretionary

Michelson Medical Research Foundation, Inc. reported holding 480,600 shares of CNNE (CANNAE HLDGS INC) in its Q3 2026 13F filing — a position valued at US$7.4M, representing 6.55% of its reported portfolio and ranking #7 among its reported holdings. Michelson Medical Research Foundation, Inc. has disclosed CNNE holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)480.60K sh
Reported value held$7.37M
Portfolio Weight6.55%
First reportedQ1 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Michelson Medical Research Foundation, Inc.'s CNNE position evolved

Michelson Medical Research Foundation, Inc. first disclosed a stake in CNNE in Q1 2026 at 480,600 shares (US$5.5M). The position peaked in Q3 2026 at 480,600 shares, worth US$7.4M. Across 3 filings, Michelson Medical Research Foundation, Inc. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 480,600 shares valued at US$7.4M.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 480.60K $5.46M New
Q2 2026 480.60K $6.92M Hold
Q3 2026 480.60K $7.37M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CNNE and 13F data

CNNE (CANNAE HLDGS INC) is a Consumer Discretionary company. 19 other funds we track also report a position in CNNE — the largest reported positions include CARRONADE CAPITAL MANAGEMENT, LP (US$46.5M), Newtyn Management, LLC (US$45.6M), PRIVATE MANAGEMENT GROUP INC (US$34.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CNNE

All CNNE fund holders →

FAQ

How long has Michelson Medical Research Foundation, Inc. held CNNE?

Michelson Medical Research Foundation, Inc. has disclosed CNNE holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Michelson Medical Research Foundation, Inc.'s current position in CNNE?

As of Q3 2026, Michelson Medical Research Foundation, Inc. holds 480.60K shares of CNNE (CANNAE HLDGS INC), valued at $7.37M, representing 6.55% of its reported portfolio and ranking #7.

Has Michelson Medical Research Foundation, Inc. been buying or selling CNNE?

In the latest 13F filing (Q3 2026), Michelson Medical Research Foundation, Inc. held unchanged its position in CNNE. The position peaked in Q3 2026 at 480.60K shares.

Which other funds hold CNNE?

Other major institutional holders of CNNE include CARRONADE CAPITAL MANAGEMENT, LP, Newtyn Management, LLC, PRIVATE MANAGEMENT GROUP INC, among 19 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.